AC-25793

N/A

Report date: 2025/01/26 15:16:32
NME

Base Information

Drug NameAC-25793
Drug Alias Nameneurotrophin signaling modulator (AlzeCure/Karolinska Institutet)NGF/TrkA and BDNF/TrkB signaling enhancer (AlzeCure/Karolinska Institutet)AC-25793
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurotrophic tyrosine kinase receptor type 2 stimulantsBrain-derived neurotrophic factor modulatorsNerve growth factor receptor Trk-A activators +[4] 
TargetsNerve growth factor receptorsNerve growth factor receptor Trk-ABrain-derived neurotrophic factor +[4] 
Therapy Area/IndicationsNerve DegenerationAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlzeCure Foundation
China Registration ClassN/A

Develop Information

Active CompaniesAlzeCure FoundationKarolinska Institutet
Inactive CompaniesN/A
Active IndicationsNerve DegenerationAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A